NSAIDs inhibit glioma invasion in vitro by dephosphorylation of Akt, which causes a decrease in MMP-2 gene expression and activity (Lee et al., 2005; Paw et al., 2015). The gene discussed is AKT1; the disease is central nervous system cancer.